Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
- PMID: 24467978
- DOI: 10.1016/j.ijcard.2013.12.101
Increased soluble ST2 is a stronger predictor of long-term cardiovascular death than natriuretic peptides in heart failure patients with reduced ejection fraction
Keywords: BNP; Biomarker; Heart failure; NT-proBNP; ST2; proBNP(1–108).
Similar articles
-
Novel biomarkers in heart failure with preserved ejection fraction.Heart Fail Clin. 2014 Jul;10(3):471-9. doi: 10.1016/j.hfc.2014.04.005. Heart Fail Clin. 2014. PMID: 24975910 Review.
-
Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.J Am Coll Cardiol. 2014 Jan 21;63(2):158-66. doi: 10.1016/j.jacc.2013.07.087. Epub 2013 Sep 24. J Am Coll Cardiol. 2014. PMID: 24076531
-
Growth differentiation factor 15, ST2, high-sensitivity troponin T, and N-terminal pro brain natriuretic peptide in heart failure with preserved vs. reduced ejection fraction.Eur J Heart Fail. 2012 Dec;14(12):1338-47. doi: 10.1093/eurjhf/hfs130. Epub 2012 Aug 5. Eur J Heart Fail. 2012. PMID: 22869458
-
Impact of diabetes on the predictive value of heart failure biomarkers.Cardiovasc Diabetol. 2016 Nov 3;15(1):151. doi: 10.1186/s12933-016-0470-x. Cardiovasc Diabetol. 2016. PMID: 27809845 Free PMC article.
-
Drug and device effects on peak oxygen consumption, 6-minute walk distance, and natriuretic peptides as predictors of therapeutic effects on mortality in patients with heart failure and reduced ejection fraction.Circ Heart Fail. 2011 Sep;4(5):578-88. doi: 10.1161/CIRCHEARTFAILURE.111.961573. Epub 2011 Jun 24. Circ Heart Fail. 2011. PMID: 21705485 Review.
Cited by
-
Soluble ST2 Testing: A Promising Biomarker in the Management of Heart Failure.Arq Bras Cardiol. 2016 Feb;106(2):145-52. doi: 10.5935/abc.20150151. Epub 2016 Jan 15. Arq Bras Cardiol. 2016. PMID: 26761075 Free PMC article. Review.
-
Stretch, Injury and Inflammation Markers Evaluation to Predict Clinical Outcomes After Implantable Cardioverter Defibrillator Therapy in Heart Failure Patients With Metabolic Syndrome.Front Physiol. 2018 Jun 26;9:758. doi: 10.3389/fphys.2018.00758. eCollection 2018. Front Physiol. 2018. PMID: 29997521 Free PMC article.
-
Soluble ST2: A Novel Biomarker for Diagnosis and Prognosis of Cardiovascular Disease.Curr Med Sci. 2024 Aug;44(4):669-679. doi: 10.1007/s11596-024-2907-x. Epub 2024 Aug 3. Curr Med Sci. 2024. PMID: 39096477 Review.
-
Development of a Novel Homogeneous Nanoparticle-Based Assay for Rapid and High-Throughput Quantitation of the sST2 Protein in Human Serum.Int J Nanomedicine. 2020 Dec 30;15:10539-10546. doi: 10.2147/IJN.S285899. eCollection 2020. Int J Nanomedicine. 2020. PMID: 33408473 Free PMC article.
-
ST2 and Galectin-3: Ready for Prime Time?EJIFCC. 2016 Aug 1;27(3):238-52. eCollection 2016 Aug. EJIFCC. 2016. PMID: 27683537 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials